IDXG

Interpace Biosciences, Inc. Common Stock
IDXG

Overview Fund Activity
Delisted

IDXG was delisted on the 24th of February, 2021.

Back to rankings

26 hedge funds and large institutions have $36.5M invested in Interpace Biosciences, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
-3
Holders Change %
-10.34%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HA
Heartland Advisors
Wisconsin
+$1.41M
2
KCM
Kennedy Capital Management
Missouri
+$740K
3
BCM
Bridgeway Capital Management
Texas
+$120K
4
GT
Glenmede Trust
Pennsylvania
+$97.4K
5
TRCT
Tower Research Capital (TRC)
New York
+$30.8K

Top Sellers

1
KSC
Kendall Square Capital
California
-$2.54M
2
WI
WHV Investments
California
-$219K
3
Goldman Sachs
Goldman Sachs
New York
-$74K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$70.9K
5
LMF
LMR Master Fund
Cayman Islands
-$58K
Name Holding Trade Value Shares
Change 		Shares
Change %
BNP Paribas Financial Markets
26
BNP Paribas Financial Markets
France
$34 – – –
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5 – – –
KSC
28
Kendall Square Capital
California
– -$2.54M -5,265 Closed
WI
29
WHV Investments
California
– -$219K -454 Closed
Goldman Sachs
30
Goldman Sachs
New York
– -$74K -153 Closed
LMF
31
LMR Master Fund
Cayman Islands
– -$58K -120 Closed
1
2